Cargando…
Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut
AIMS/HYPOTHESIS: Variants in the TCF7L2 gene remain the strongest genetic associations with increased risk of type 2 diabetes. Recently, we identified a unique splicing form of TCF7L2 expressed in pancreatic islets, pancreas and colon and detected by assay ‘ex13-13b’. The expression of ex13-13b stro...
Autores principales: | Prokunina-Olsson, L., Hall, J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830605/ https://www.ncbi.nlm.nih.gov/pubmed/20033802 http://dx.doi.org/10.1007/s00125-009-1640-0 |
Ejemplares similares
-
No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009) -
Tissue-specific alternative splicing of TCF7L2
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009) -
Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009) -
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants
por: Redondo, Maria J., et al.
Publicado: (2022) -
No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
por: Goode, Ellen L, et al.
Publicado: (2009)